Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience
YH Kim, G Martinez, A Varghese… - Archives of …, 2003 - jamanetwork.com
Objective To evaluate and update the response and survival outcomes and toxic effects in
patients treated with topical nitrogen mustard (mechlorethamine hydrochloride) as primary
therapy. Design A single-center, retrospective cohort analysis. Setting Academic referral
center for cutaneous lymphoma. Patients A total of 203 patients with mycosis fungoides
(clinical stages I-III) treated with topical nitrogen mustard as initial therapy. Main Outcome
Measures Long-term actuarial survival, freedom-from-relapse, and freedom-from …
patients treated with topical nitrogen mustard (mechlorethamine hydrochloride) as primary
therapy. Design A single-center, retrospective cohort analysis. Setting Academic referral
center for cutaneous lymphoma. Patients A total of 203 patients with mycosis fungoides
(clinical stages I-III) treated with topical nitrogen mustard as initial therapy. Main Outcome
Measures Long-term actuarial survival, freedom-from-relapse, and freedom-from …